Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (101-110 of 2,959) with videos related to

Pageof 296
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1996
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
American Journal of Surgery|April 1, 1991
Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosisJ Hirsh
American Heart Journal|June 17, 1998
Low-molecular-weight heparin for the treatment of venous thromboembolismJ Hirsh
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1986
Diagnosis of thrombophlebitisJ Hirsh
Vascular Medicine (London, England)|January 1, 1996
New antithrombotics for the treatment of acute and chronic arterial ischemiaJ Hirsh
Thrombosis Research|June 24, 2003
Current anticoagulant therapy--unmet clinical needsJack Hirsh
Advances in Experimental Medicine and Biology|January 1, 1992
Relationship between dose, anticoagulant effect and the clinical efficacy and safety of heparinJ Hirsh
Nature|November 17, 1994
Molecular genetics. Operons in eukaryotes follow the spliced leaderD Hirsh
The American Journal of Cardiology|February 23, 1995
ThrombosisJ Hirsh
The American Journal of Cardiology|February 23, 1995
Optimal intensity and monitoring warfarinJ Hirsh
Pageof 296

Showing results (101-110 of 2,959) with videos related to

Sort By:
Pageof 296
Seminars in Thrombosis and Hemostasis|January 1, 1996
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
American Journal of Surgery|April 1, 1991
Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosisJ Hirsh
American Heart Journal|June 17, 1998
Low-molecular-weight heparin for the treatment of venous thromboembolismJ Hirsh
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1986
Diagnosis of thrombophlebitisJ Hirsh
Vascular Medicine (London, England)|January 1, 1996
New antithrombotics for the treatment of acute and chronic arterial ischemiaJ Hirsh
Thrombosis Research|June 24, 2003
Current anticoagulant therapy--unmet clinical needsJack Hirsh
Advances in Experimental Medicine and Biology|January 1, 1992
Relationship between dose, anticoagulant effect and the clinical efficacy and safety of heparinJ Hirsh
Nature|November 17, 1994
Molecular genetics. Operons in eukaryotes follow the spliced leaderD Hirsh
The American Journal of Cardiology|February 23, 1995
ThrombosisJ Hirsh
The American Journal of Cardiology|February 23, 1995
Optimal intensity and monitoring warfarinJ Hirsh
Pageof 296